Remark Pharma Services & Consulting
Private Company
Funding information not available
Overview
Founded in 2008, Remark Pharma is a private, revenue-generating service provider in the life sciences sector, operating from Munich, Germany. The company functions as a specialized consultancy, offering critical support in clinical operations, regulatory strategy, and medical affairs to pharmaceutical and biotech clients. Its business model is centered on providing expert services rather than developing its own therapeutic assets, positioning it as a key enabler for drug development programs. The company addresses the growing need for specialized external expertise in an increasingly complex and globalized regulatory environment.
Technology Platform
Integrated service model and expertise in clinical operations, regulatory affairs, and medical affairs, with specialized knowledge in Drug Delivery and Digital Health regulatory strategies.
Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded market competing against large, full-service global CROs (e.g., IQVIA, Parexel) and numerous small-to-mid-sized specialized consultancies. Differentiation is achieved through deep, focused expertise in European regulatory affairs and specific technical sectors like Drug Delivery.